{
    "2021-02-17": [
        [
            {
                "time": "",
                "original_text": "奥博、红杉齐聚！三年九倍的CRO细分龙头，低价弯腰捡筹码的机会来了！",
                "features": {
                    "keywords": [
                        "奥博",
                        "红杉",
                        "CRO",
                        "细分龙头",
                        "低价",
                        "捡筹码"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【异动股】泰格医药(03347-HK)涨3.21%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "异动股",
                        "涨3.21%"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股打新 | 昭衍新药(06127)AH两地上市，A股上市累计涨幅20多倍",
                "features": {
                    "keywords": [
                        "港股打新",
                        "昭衍新药",
                        "AH两地上市",
                        "A股",
                        "涨幅20多倍"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(03347.HK)获摩根士丹利增持29.7万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "摩根士丹利",
                        "增持",
                        "29.7万股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}